Additionally, the interaction between lncRNA-PDPK2P and PDK1 promotes the development of HCC through the PDK1/AKT/caspase 3 signaling pathway and makes it a promising molecular target for HCC treatment (22). The gene discussed is PDPK2P; the disease is hepatocellular carcinoma.